Rchr
J-GLOBAL ID:201901019421199009
Update date: Jan. 30, 2024 Takashi Kijima
KIJIMA TAKASHI | Takashi Kijima
Affiliation and department: Research field (1):
Respiratory medicine
Research theme for competitive and other funds (9): - 2022 - 2026 Treatment response and prognosis prediction of immune checkpoint inhibitors by FDG-PET/CT: A Japanese multicenter prospective study
- 2021 - 2024 呼吸動態の力学的な理解にもとづいた呼吸器疾患の新規診断法の開発
- 2020 - 2023 肺癌治療において分子標的治療薬が惹起する薬剤性肺障害の発症機序の解明とその克服
- 2018 - 2021 Identification of molecular mechanism underlying malignant mesothelioma development using conditional mouse model and search of therapeutic target molecules
- 2018 - 2021 Development of innovative nucleic acid medicine using EPR enhancer iNaD
- 2015 - 2018 Developing novel lung cancer therapy targetting cancer cell intrinsic ligands
- 2012 - 2015 HER2 target therapy for multidrug-resistant small cell lung cancer
- 2009 - 2011 Molecular target therapy for multidrug-resistant small cell lung cancer
- 2005 - 2006 The Induction of Decsity-Deoendent Inhibition of Cell Growth in Malignant Mesothelioma Cells by the Extracellular Domain of erbB2 for Reduction of Growth of Mesothelioma
Show all
Return to Previous Page